2017 Executive Sponsors

Bioclinica
Imaging Endpoints
Mitra Biotech
nanoString Technologies
NeoGenomics
US Oncology Research

2017 Associate Sponsors

Adaptive Biotechnologies
Beigene
BioLegend
Cytel
Defined health
Immodulon Therapeutics
inVentiv Health
MacroGenics
Miltenyi Biotec
Neon Therapeutics
Parexel
Vector Vitale

2017 Exhibitors

Abcam
Axio Research
Caprion
Intrinsic Imaging
KIYATEC Inc
Personalis
QuickStat
World Courier

Supporting Partners

CIMT
CRI
Patient Empowerment
SITC

2017 Media Partners

BioPharm Insight
BioPharma Dive
CanBiotech
Clinical Leader
Life Science Leader
MNT
Pharmaceutical Online
Pharmalicensing
Pharmaphorum
PharmaVOICE
SciDoc Publishers
Technology Networks

Who Should Attend

The program is designed for large pharma, mid-sized biopharma, biotechs and investors seeking to accelerate clinical trials in the emerging immuno oncology space.

Large Pharma/Biopharma/Biotech responsible for:

  • R&D: Clinical Research/Development, Clinical Operations, Clinical Oncology, Cancer Immunotherapy, Immunology, Translational Research/Development/Medicine, Medical Affairs, R&D Innovation & Strategy, Biomarkers
  • Business Development: Corporate Venture, Licensing, Strategic Partnerships, Negotiations, Early-stage Collaboration, Commercial Innovation, External R&D

Investment Community:

  • Investment Firms
  • Venture Capitals
  • Banks/Financial Institutions
  • Foundation Capital

Academia & Research Organizations focusing on:

  • Immuno-Oncology
  • Immunotherapy
  • Oncology
  • Immunology
  • Immunobiology
  • Cancer Vaccines
  • Clinical Research and Development

Solution Providers:

  • CROs
  • Consultants/Advisors
  • Law Firms
  • Technology/Medical Device Platforms

Our audience is as much a part of the event as our speaking faculty. Our ultimate goal is to foster a Summit environment that inspires positive change in immuno oncology and support for all those involved in the movement. If you are interested in joining the speaking faculty or audience, please email us at Customer Service.